U.S.-related Lyme Disease (Unusual Presentation)

Overview

Lyme disease is a bacterial infection caused by Borrelia burgdorferi (and, in the western United States, B. mayonii). In the United States, most cases are transmitted by the bite of infected black‑legged (deer) ticks (*Ixodes scapularis*) in the Northeast, Mid‑Atlantic, and Upper Midwest, and by the western black‑legged tick (*Ixodes pacificus*) on the Pacific Coast.

While the classic triad of erythema migrans (EM) rash, fever, and arthralgia is well‑known, about 10‑30% of patients experience atypical or “unusual” manifestations—neurologic, cardiac, or multisystem involvement without the classic rash. Recognizing these patterns is essential because delayed diagnosis can lead to long‑term disability.

Prevalence: According to the CDC, ~35,000 cases are reported annually in the U.S., but the actual number is likely 10‑12 times higher due to under‑reporting. Unusual presentations account for roughly 15% of confirmed cases, affecting both adults and children, though adults >50 years old are at slightly higher risk for cardiac or neurologic complications.

Symptoms

Symptoms may appear in stages but can overlap, especially in atypical cases. Below is a comprehensive list with brief descriptions.

Early Localized (3‑30 days after bite)

• Erythema migrans (EM) rash – Expanding red ring, often “bull’s‑eye”; may be absent in up to 30% of cases.
• Flu‑like symptoms – Fever, chills, headache, fatigue, muscle aches.
• Joint pain – Usually mild, affecting shoulders, knees, or elbows.

Early Disseminated (weeks to months)

• Multiple EM lesions – New rashes at sites distant from the bite.
• Neurologic – Bell’s palsy (facial nerve palsy), meningitis‑type headache, neck stiffness, cranial neuropathies, radiculopathy.
• Cardiac – Lyme carditis presenting as atrioventricular (AV) block, myocarditis, or pericarditis. May cause palpitations, light‑headedness, or syncope.
• Ophthalmic – Conjunctivitis, uveitis, optic neuritis (rare).
• Fever, chills, and malaise may persist.

Late Disseminated (months to years)

• Lyme arthritis – Recurrent, episodic swelling of large joints (most often the knee).
• Chronic neurologic disease – Peripheral neuropathy, encephalopathy, memory problems (“brain fog”), sleep disturbances.
• Cardiac sequelae – Persistent conduction defects.
• Fatigue, depression, and generalized pain (often called post‑treatment Lyme disease syndrome).

Unusual/ atypical presentations

• Absence of rash (≈30% of U.S. patients).
• Acute or chronic facial nerve palsy without other systemic signs.
• Isolated AV block without preceding EM.
• Hearing loss or vestibular dysfunction.
• Severe, migratory musculoskeletal pain mimicking rheumatoid arthritis.
• Cutaneous manifestations other than EM (e.g., acrodermatitis chronica atrophicans—rare in the U.S.).

Causes and Risk Factors

Cause

Lyme disease is caused by spirochete bacteria of the genus Borrelia. The organisms reside in the mid‑gut of unfed nymphal and adult ticks. When an infected tick attaches and feeds for ≥36–48 hours, the bacteria migrate to the tick’s salivary glands and are transmitted to the host.

Risk Factors

• Geographic exposure – Living in or traveling to endemic regions (Northeast, Upper Midwest, Pacific Coast).
• Outdoor activities – Hiking, camping, gardening, hunting during spring‑early summer when nymphs are active.
• Age – Children ≤15 years and adults >50 years have higher incidence.
• Pet ownership – Dogs and cats can bring ticks into the home.
• Land use – Suburban areas with fragmented forest edge create ideal tick habitats.
• Immune status – Immunocompromised individuals may have more severe disease.

Diagnosis

Because the presentation can be atypical, diagnosis relies on a combination of clinical suspicion, exposure history, and laboratory testing.

Clinical Assessment

• Detailed tick exposure history (date, location, duration of attachment).
• Physical exam focused on rash, neurologic signs, cardiac rhythm, joint swelling.

Laboratory Tests

1. Two‑tier serology (CDC‑recommended)
   • First tier: Enzyme‑linked immunoassay (ELISA) or immunofluorescence assay (IFA) for IgM and IgG antibodies.
   • Second tier: If ELISA positive or equivocal, reflex to Western blot (separate IgM and IgG criteria). Positive IgM <30 days; IgG after 30 days.
2. Direct detection (less common)
   • Polymerase chain reaction (PCR) on synovial fluid, cerebrospinal fluid (CSF), or skin biopsy – useful for arthritis or neuro‑Lyme.
   • Culture – technically possible but rarely performed due to low yield.
3. CSF analysis (if meningitis or radiculopathy suspected) – reveals lymphocytic pleocytosis, elevated protein, and intrathecal production of Borrelia‑specific antibodies.

Diagnostic Challenges in Unusual Presentations

Absence of EM may delay testing. It is crucial to order serology early (≥2–3 weeks after exposure) because antibodies may not be detectable in the first week. False‑negative early tests should be repeated if clinical suspicion remains high.

Treatment Options

Treatment is dictated by disease stage, organ involvement, and patient factors (age, pregnancy, allergies). Oral antibiotics are effective for most early cases; intravenous therapy is reserved for certain neurologic or cardiac manifestations.

Early Localized & Disseminated Disease

• Doxycycline 100 mg PO twice daily for 10–21 days – First‑line for adults and children ≥8 years; also covers co‑infection with *Anaplasma* spp.
• Amoxicillin 500 mg PO three times daily for 14–21 days – Preferred for pregnant women, infants <8 years, or doxycycline‑intolerant patients.
• Cefuroxime axetil 500 mg PO twice daily for 14–21 days – Alternative to amoxicillin.

Neurologic Involvement (e.g., meningitis, cranial neuropathy)

• Intravenous ceftriaxone 2 g daily (or 1 g BID) for 14–28 days – Recommended by IDSA and AAN guidelines.
• In rare cases, penicillin G or cefotaxime may be used.

Cardiac Lyme (AV block, myocarditis)

• IV ceftriaxone is first‑line for high‑grade AV block (second‑degree Type II or complete block).
• Oral doxycycline may be used for milder conduction defects, but close cardiac monitoring is essential.
• Temporary pacing may be required if symptomatic bradycardia persists.

Late Disseminated (Arthritis)

• Oral doxycycline, amoxicillin, or cefuroxime for 28 days.
• If arthritis persists after antibiotics, intra‑articular glucocorticoid injection may be considered.

Adjunctive & Lifestyle Measures

• Rest, hydration, and analgesics (acetaminophen or NSAIDs) for symptom relief.
• Physical therapy for joint stiffness after acute inflammation resolves.
• Management of co‑infections (e.g., *Anaplasma* – doxycycline covers both).

Living with U.S.-related Lyme Disease (Unusual Presentation)

Even after completing treatment, many patients experience lingering fatigue, cognitive fog, or intermittent joint pain. Below are practical strategies to improve quality of life.

Energy Management

• Prioritize tasks and schedule “rest periods” throughout the day—use the “pomodoro” technique (25 min work, 5 min rest).
• Gentle aerobic activity (walking, swimming) 3–4 times/week can boost stamina without overtaxing joints.

Cognitive Support

• Use memory aids—apps, notebooks, and alarms.
• Break complex activities into smaller steps; practice mindfulness meditation to improve focus.

Joint Care

• Apply warm compresses before gentle stretching; cold packs for acute swelling.
• Engage in low‑impact strength training (resistance bands) to maintain muscle support around affected joints.

Emotional Well‑being

• Consider counseling or support groups (e.g., Lyme Disease Association forums).
• Educate family and coworkers about the disease to reduce misunderstanding and stigma.

Follow‑up and Monitoring

• Schedule a follow‑up visit 2–4 weeks after completing antibiotics to evaluate symptom resolution.
• If joint swelling recurs, repeat serology and consider imaging (ultrasound or MRI).
• Cardiac monitoring (e.g., Holter) is advisable for anyone who had Lyme carditis.

Prevention

1. Tick avoidance
   • Stay on cleared paths; avoid dense underbrush during peak tick season (May‑July).
   • Wear long sleeves, long pants, and light-colored clothing to spot ticks.
2. Tick checks
   • Inspect whole body (including scalp, behind ears, groin) within 24 hours of outdoor exposure.
   • Shower promptly—water can help wash away unattached ticks.
3. Proper tick removal
   • Use fine‑point tweezers; grasp close to skin and pull upward with steady pressure.
   • Disinfect the bite site with alcohol or iodine.
4. Environmental measures
   • Keep lawns mowed, remove leaf litter, and create a 3‑foot barrier of wood chips between forested areas and play yards.
   • Consider acaricide treatments for pets and yard perimeters (consult local extension office).
5. Vaccination – As of 2024, no U.S.‑approved Lyme vaccine is commercially available, though several candidates are in phase III trials (NIH). Keep an eye on FDA updates.

Complications

If untreated or inadequately treated, Lyme disease can lead to serious, sometimes irreversible complications:

• Chronic neurological deficits – Persistent facial palsy, peripheral neuropathy, encephalopathy, and seizures.
• Cardiac sequelae – Permanent AV block requiring pacemaker implantation.
• Severe arthritis – Joint erosion and deformity after repeated inflammatory episodes.
• Hepatitis, renal involvement – Rare but documented in disseminated disease.
• Co‑infection morbidity – Simultaneous infection with *Anaplasma phagocytophilum* or *Babesia microti* can cause severe anemia, thrombocytopenia, and organ failure.

When to Seek Emergency Care

---

References:

1. Mayo Clinic. Lyme disease: Symptoms and causes. 2023.
2. Centers for Disease Control and Prevention. Lyme Disease Statistics. Updated 2024.
3. National Institute of Allergy and Infectious Diseases. Lyme Disease. 2022.
4. Infectious Diseases Society of America (IDSA). Clinical Practice Guidelines for Lyme Disease. 2021.
5. Cleveland Clinic. Lyme disease. 2024.
6. World Health Organization. Lyme disease fact sheet. 2023.